About

Sherri Sheinfeld Gorin, Ph.D., FSBM, is the Founder and Director of the New York Physicians Against Cancer (NYPAC). A Fulbright Distinguished Senior Scholar, her experience includes serving as a Senior Scientific Consultant (Leidos) to the Division of Cancer Control and Population Sciences, National Cancer Institute, U.S. National Institutes of Health; Professor of Medicine, University of Michigan and School of Public Health, and Member, Rogel Cancer Center. She led as Professor of Health Services Research, Mayo Clinic College of Medicine, and previously, Associate Professor, Columbia University, and Member, Herbert Irving Comprehensive Cancer Center.

She established and directed their first Mayo Clinic Office of Cancer Health Disparities Research, a unique entity among comprehensive cancer centers nation-wide. A Fellow of the Society of Behavioral Medicine, she has authored over 250 peer-reviewed publications, book chapters, and presentations.

She has also published three books: The Health Promotion Handbook, Health Promotion in Practice (first edition), and Prevention Practice in Primary Care. She serves as a reviewer and/or editorial board member for more than 40 scientific journals, including the Annals of Family Medicine, and has held three Special Issue editorships of Vaccines.

She has held positions of leadership in cancer prevention and control research with an emphasis on health disparities across the government, non-profit, and academic sectors, worldwide. She is a member of numerous consortia, community, and scientific advisory boards, and is the recipient of the Society of Behavioral Medicine's "Research to Practice" Award, the International Society of Behavioral Medicine's "Distinguished Career Achievement Award," and awards from the American Association of Cancer Research and Frontiers in Cancer Prevention, among other honors.

Her scholarly interests are both deep and broad, spanning the fields of cancer epidemiology, health services research, behavioral medicine, and implementation science. Her primary interests are in the implications of inequities in cancer prevention, screening, and treatment outcomes for breast, colorectal, prostate, and cervical cancers, and the implementation of multi-level, theory-based interventions to reduce cancer-related health disparities in diverse subgroups. Some of her more recent work explores the application of interactive, digital, and web-based multimedia patient-reported outcomes to translate behavioral science findings into improved patient-centered care in under-resourced settings, worldwide.

As an epidemiologist and a behavioral scientist, she has lengthy experience and practiced skills in leading large-scale rigorous research projects in vulnerable communities, as well as within underserved communities in low- and middle-income countries. At present, she and her team are conducting a series of projects to design, implement, and evaluate scalable multi-level interventions to decrease HPV vaccine hesitancy; these understandings have extended to projects on COVID-19 vaccine uptake behaviors. She has mentored scores of students, including, most recently, Ugandan, Tanzanian, and Democratic Republic of the Congo-based physicians who have successfully completed their IMPH at Hebrew University to return to leadership positions in Ministries of Health and of large academic medical centers.

Throughout her scientific career, her lab and she have focused on developing and testing theory-based dissemination and implementation models to bring groundbreaking cancer control technologies to underserved populations, worldwide.